In an animal model of Alzheimer's disease (AD), the upregulation of irisin signaling in the brain increased neuronal synaptic strength and antagonized pathophysiological processes involved in the development and progression of AD, such as reduced binding of neurotoxic soluble amyloid-beta peptides to neurons [57]. This evidence concerns the gene FNDC5 and Alzheimer disease.